BRC Group RILYP Earnings Outlook Key Metrics for Q1 2024 Jason Collins NBA Trailblazer Dies at 47 Potential Impact on Sports and Brand Sponsorships Mobile Infra BEEP Delivers Q1 2026 Beat EPS 010 vs 010 Expected Microvast Holdings MVST Q1 2026 Financial Overview Arm Holdings ARM Evaluating Its Position Among European Growth Stocks BJs Wholesale Plans Store Overhaul as Consumers Tighten Spending Amazon Faces Allegations Over Previously Legal Policy That Generated Millions Yardeni Warns the Fed May Face Pressure to Raise Rates in July as Bond Vigilantes Return Disneys Ahsoka Season 2 Shows Cost Discipline 30 Cheaper Than The Acolyte London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance CZWI Q1 2026 Earnings EPS Beats Estimates Revenue Data Not Disclosed MGIC Investment MTG Q1 2026 Earnings Modest EPS Beat as Mortgage Insurance Premiums Steady BCC Q1 2026 Earnings Earnings Beat Expectations Amid Challenging Market Conditions AMWL Q1 2026 Earnings EPS Beats Estimates by Wide Margin as Cost Controls Drive Improvement ZD Q1 2026 Earnings EPS Misses Estimates Stock Rises on Strategic Progress GWAV Q3 2023 Earnings Negative EPS Reported Stock Rises 225 Prudential Financial PRS Notes Edge Lower Amidst Modest Selloff Cummins Inc CMI Surges 457 as Strong Momentum Builds CF Financial CFFI Holds Steady Near Support as LowVolume Drift Continues Crown Crafts Inc CRWS Posts Modest Gain Tests Key Resistance Zone Primerica PRI Holds Steady Near Support as Sector Dynamics Shift Brookfield Renewable Partners BEP Holds Steady as Renewable Energy Sector Faces Mixed Signals Aldabra 4 Liquidity Opportunity Vehicle Inc ALOVU Holds Steady at 1005 Amid Low Volatility MoneyHero Limited Warrants MNYWW Slips 6 as PennyStock Range Tightens GCI Liberty GLIBK Rallies 179 Approaching Resistance at 2445 Ares Capital Corporation ARCC Edges Higher as Stock Holds Within Established Range Brown Brown Inc BRO Holds Steady Near Support as Resistance Looms College Degree No Longer Guarantees Prosperity for Gen Z Survey Data Suggests CLDT Q1 2026 Earnings EPS Surpasses Expectations Narrowing Loss CRISPR Therapeutics Consolidates Near Support as Gene Editing Sector Awaits Catalysts